Trasylol Lawsuit & News Blog
Blog Home
Archives
Articles
Category Index
Trasylol - Kidney Failure & Stroke - Dialysis Centers and Stroke Resources
Article Index
Kidney Damage Increases with Coronary Artery Bypass Surgery
Bayer Suspends Two Employees over Trasylol Data
Bayer Purposely Does Not Disclose Trasylol Dangers
Bayer Discloses Trasylol (aprotinin) Trials Not Disclose Facts
FDA Statement Regarding New Trasylol Data
Bayer insists that Trasylol heart drug is safe
Trasylol (aprotinin) now proves to double a patient's risk of kidney failure
Bayer insists that Trasylol heart drug is safe
Is Aprtoninin treatment worth the risk of kideny failure, stroke, or heart attack?
Trasylol Lawsuits
Trasylol Lawyers & Attorneys | Trasylol Side Effects
Trasylol Patients and Clinical Trial Subjects Beware
Trasylol Patients and Clinical Trial Subjects Beware
Bayer AG can expect a slowdown in the growth in sales of its blood loss drug Trasylol, after an independent study showed that the drug was associated with health risks, board member Wolfgang Plischke said after the full-year results news conference
Drug Alert - Trasylol Blamed For Lethal Injuries During Surgery
